CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	0.01	0.02	0.03	0.13	0.12	1.39
Cash & Short-Term Investments	0.01	0.02	0.03	0.13	0.12	1.39
Cash Growth	-73.39%	-42.80%	-79.63%	10.37%	-91.52%	78.30%
Prepaid Expenses	0	0	0	0.09	0.08	0.2
Total Current Assets	0.01	0.02	0.03	0.22	0.2	1.59
Property, Plant & Equipment	-	-	-	0.27	0.44	0.64
Long-Term Investments	-	-	-	-	0.18	0.85
Total Assets	0.01	0.02	0.03	0.5	0.81	3.08
Accounts Payable	0.04	0.05	0.04	0.34	0.46	0.18
Accrued Expenses	-	1.04	0.93	0.61	-	-
Short-Term Debt	1.17	1.2	1.3	1.34	1.76	0.87
Other Current Liabilities	1.34	0.22	0.24	0.22	0.22	0.22
Total Current Liabilities	2.55	2.51	2.51	2.52	2.44	1.27
Other Long-Term Liabilities	-	-	-	-	0	-
Total Liabilities	2.55	2.51	2.51	2.52	2.44	1.27
Common Stock	0.11	0.06	0	0	0	0.01
Additional Paid-In Capital	22.78	22.72	22.47	22.24	18.03	17.06
Retained Earnings	-25.43	-25.27	-24.95	-24.26	-20.55	-16.83
Comprehensive Income & Other	-	-	-	-	0.88	1.55
Shareholders' Equity	-2.53	-2.5	-2.48	-2.02	-1.63	1.81
Total Liabilities & Equity	0.01	0.02	0.03	0.5	0.81	3.08
Total Debt	1.17	1.2	1.3	1.34	1.76	0.87
Net Cash (Debt)	-1.15	-1.18	-1.27	-1.21	-1.64	0.51
Net Cash Growth	-	-	-	-	-	-33.83%
Net Cash Per Share	-0.00	-0.01	-0.04	-0.14	-1.34	0.45
Filing Date Shares Outstanding	1,226	753.2	31.11	28.31	1.26	1.24
Total Common Shares Outstanding	1,126	553.96	31.11	22.61	1.26	1.24
Working Capital	-2.53	-2.5	-2.48	-2.29	-2.25	0.32
Book Value Per Share	-0.00	-0.00	-0.08	-0.09	-1.30	1.46
Tangible Book Value	-2.53	-2.5	-2.48	-2.02	-1.63	1.81
Tangible Book Value Per Share	-0.00	-0.00	-0.08	-0.09	-1.30	1.46

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.